Skip to content

Evaluation of the pleiotropic effects of statins: a reanalysis of the randomized trial evidence using Egger regression

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)262-265
Number of pages4
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Issue number1
Early online date9 Nov 2017
DateAccepted/In press - 24 Oct 2017
DateE-pub ahead of print - 9 Nov 2017
DatePublished (current) - 1 Jan 2018


Objective—To reanalyze data from recent randomized trials of statins to assess whether the benefits and risks of statins are mediated primarily via their LDL-C (low-density lipoprotein cholesterol) lowering effects or via other mechanisms.
Approach and Results—We adapted Egger regression, a technique frequently used in Mendelian randomization studies to detect genetic pleiotropy, to reanalyze the available randomized control trial data of statin therapy. For cardiovascular end points, each 1 mmol/L change in LDL-C with statin therapy was associated with a hazard ratio of 0.77 (95% confidence interval, 0.71–0.84) with an intercept that was indistinguishable from zero (intercept, −0.0032; [95% confidence interval, −0.090 to 0.084]; P=0.94), indicating no pleiotropy. For incident diabetes mellitus, a 1 mmol/L change in LDL-C with statin therapy was associated with a hazard ratio of 1.07 (95% confidence interval, 0.99–1.16) and an intercept nondistinguishable from zero (intercept, −0.015; [95% confidence interval, −0.30 to 0.27]; P=0.91), again indicating no pleiotropy.
Conclusions—Our reanalysis of the randomized control trial data using Egger regression adds to the existing evidence that the cardiovascular benefits of statins and their association with incident diabetes mellitus are mediated primarily, if not entirely, via their LDL-C lowering properties rather than by any pleiotropic effects.

    Research areas

  • cholesterol, diabetes mellitus, genetic pleiotropy, inflammation, secondary prevention

Download statistics

No data available



  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the author accepted manuscript (AAM). The final published version (version of record) is available online via AHA at Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 413 KB, PDF document


View research connections

Related faculties, schools or groups